EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A platform for CRISPRi-seq in Streptomyces albidoflavus

Justin E Clarke, Tabitha R Faulkner, Ryan F Seipke iD

mBio · 2026

DOI: 10.1128/mbio.03065-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2026. Verfasst von Justin E Clarke und 2 weiteren Autor:innen. Beteiligte Einrichtung: Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom. Hauptthemen laut MEDLINE: Streptomyces, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Streptomyces produce a multitude of secondary metabolites, which have been exploited in drug discovery campaigns for more than three-quarters of a century. Our understanding of microbial physiology has been revolutionized by genome sequencing and large-scale functional studies. Technology for genome-wide investigations in Streptomyces species, however, has lagged behind that for other bacterial systems, hindering exploitation of unprecedented quantities of genomic data. Here, we develop a platform for en masse clustered regularly interspaced short palindromic repeats interference sequencing (CRISPRi-seq) for Streptomyces spp. By performing CRISPRi-seq with 2,160 unique sgRNAs targeting all operons (432 operons) encoding membrane transporters (629 genes) representing 1.1Mb of the 6.8Mb genome for S. albidoflavus, combined with hit validation, we discovered that only a small proportion (13 of 432 operons, 25 kb) contribute positively to fitness. Our work provides both a first-in-class platform for high-throughput functional genomics and a generalized blueprint for en masse screens in Streptomyces species. IMPORTANCE Streptomyces bacteria are prolific producers of clinically essential natural products, yet high-throughput tools to systematically interrogate their genomes remain underdeveloped. By establishing a robust CRISPRi-seq platform for en masse functional screening in Streptomyces albidoflavus , our work closes a critical technological gap in Streptomyces functional genomics. Our study not only identifies a small subset of transporter operons essential for fitness but also introduces a scalable, generalizable approach for dissecting gene function. This platform will accelerate systems-level understanding of an industrially and medically important genus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StreptomycesClustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsOperonGenome, BacterialGenomics

Stichwörter der Autor:innen

CRISPRiCRISPRi-seqStreptomycesessential genes

Autor:innen und Institutionen

  • Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

ORCID-Profile: Ryan F Seipke

Förderung

  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Clarke, J. E., Faulkner, T. R., & Seipke, R. F. (2026). A platform for CRISPRi-seq in Streptomyces albidoflavus. mBio. https://doi.org/10.1128/mbio.03065-25

Vancouver

Clarke JE, Faulkner TR, Seipke RF. A platform for CRISPRi-seq in Streptomyces albidoflavus. mBio. 2026. doi:10.1128/mbio.03065-25

BibTeX
@article{Clarke2026,
  author = {Clarke, Justin E and Faulkner, Tabitha R and Seipke, Ryan F},
  title = {A platform for CRISPRi-seq in Streptomyces albidoflavus},
  journal = {mBio},
  year = {2026},
  doi = {10.1128/mbio.03065-25}
}
Kostenlos starten →